What is the share price of Transchem Ltd (TRANSCHEM) today?
The share price of TRANSCHEM as on 15th September 2026 is ₹374.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Transchem Ltd (TRANSCHEM) share?
The past returns of Transchem Ltd (TRANSCHEM) share are- Past 1 week: 1.93%
- Past 1 month: 17.40%
- Past 3 months: 34.40%
- Past 6 months: 146.54%
- Past 1 year: 506.18%
- Past 3 years: 1434.84%
- Past 5 years: 1602.27%
What are the peers or stocks similar to Transchem Ltd (TRANSCHEM)?
The peers or stocks similar to Transchem Ltd (TRANSCHEM) include:What is the market cap of Transchem Ltd (TRANSCHEM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Transchem Ltd (TRANSCHEM) is ₹466.53 Cr as of 15th September 2026.What is the 52 week high and low of Transchem Ltd (TRANSCHEM) share?
The 52-week high of Transchem Ltd (TRANSCHEM) is ₹388 and the 52-week low is ₹56.01.What is the PE and PB ratio of Transchem Ltd (TRANSCHEM) stock?
The P/E (price-to-earnings) ratio of Transchem Ltd (TRANSCHEM) is 108.75. The P/B (price-to-book) ratio is 5.58.Which sector does Transchem Ltd (TRANSCHEM) belong to?
Transchem Ltd (TRANSCHEM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Transchem Ltd (TRANSCHEM) shares?
You can directly buy Transchem Ltd (TRANSCHEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Transchem Ltd
TRANSCHEM Share Price
BSE₹374.501.74% (-6.65)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TRANSCHEM Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TRANSCHEM Performance & Key Metrics
TRANSCHEM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 69.42 | 5.58 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.99 | 5.89 | 0.48% |
TRANSCHEM Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
TRANSCHEM Company Profile
Transchem Ltd is the largest producer of a wide range of Anathematic API`s (Anti-Parasitic) in the world.They also offer specialized range of human use APIs.The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India.
SUNPHARMA
PE Ratio
38.46
38.46
1Y Return
14.84%
14.84%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
87.30
87.30
1Y Return
37.33%
37.33%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.15
22.15
1Y Return
6.15%
6.15%
Buy Reco %
57.69
57.69
CIPLA
PE Ratio
28.45
28.45
1Y Return
12.80%
12.80%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
119.70
119.70
1Y Return
114.59%
114.59%
Buy Reco %
58.33
58.33
TRANSCHEM Forecast
TRANSCHEM Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
TRANSCHEM
TRANSCHEM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
TRANSCHEM Income Statement
TRANSCHEM Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.57 | 2.47 | 2.31 | 2.40 | 3.99 | 1.64 | 1.68 | 2.25 | 3.70 | 5.11 | ||||||||||
Operating & Other expenses | 0.86 | 0.27 | 0.37 | 0.54 | 2.91 | 0.28 | 0.74 | 1.31 | 1.31 | 0.70 | ||||||||||
EBITDA | 1.71 | 2.20 | 1.94 | 1.86 | 1.08 | 1.36 | 0.94 | 0.94 | 2.39 | 4.41 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | ||||||||||
| PBIT | 1.71 | 2.20 | 1.94 | 1.86 | 1.08 | 1.36 | 0.94 | 0.94 | 2.39 | 4.36 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | ||||||||||
| PBT | 1.71 | 2.20 | 1.94 | 1.86 | 1.08 | 1.36 | 0.94 | 0.94 | 2.39 | 4.35 | ||||||||||
| Taxes & Other Items | 0.46 | 0.53 | 0.49 | 0.47 | 0.35 | 0.36 | 0.26 | 0.41 | 0.30 | 0.93 | ||||||||||
| Net Income | 1.25 | 1.67 | 1.45 | 1.39 | 0.73 | 1.00 | 0.68 | 0.53 | 2.09 | 3.42 | ||||||||||
| EPS | 1.02 | 1.36 | 1.18 | 1.13 | 0.60 | 0.81 | 0.56 | 0.43 | 1.71 | 2.79 |
TRANSCHEM Company Updates
TRANSCHEM Stock Peers
TRANSCHEM Past Performance & Peer Comparison
TRANSCHEM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Transchem Ltd | 108.75 | 5.58 | — |
| Sun Pharmaceutical Industries Ltd | 38.46 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 87.30 | 10.74 | 0.68% |
| Zydus Lifesciences Ltd | 22.15 | 3.77 | 0.09% |
TRANSCHEM Stock Price Comparison
Compare TRANSCHEM with any stock or ETFCompare TRANSCHEM with any stock or ETF
TRANSCHEM
TRANSCHEM Holdings
TRANSCHEM Shareholdings
TRANSCHEM Promoter Holdings Trend
TRANSCHEM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
TRANSCHEM Institutional Holdings Trend
TRANSCHEM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TRANSCHEM Shareholding Pattern
TRANSCHEM Shareholding Pattern
TRANSCHEM Shareholding History
TRANSCHEM Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing TRANSCHEM stock
smallcases containing TRANSCHEM stock
Looks like this stock is not in any smallcase yet.
TRANSCHEM Events
TRANSCHEM Events
TRANSCHEM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TRANSCHEM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TRANSCHEM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TRANSCHEM has not given any dividends in last 5 years
TRANSCHEM Dividends
TRANSCHEM Dividends
Hmm, looks like data is unavailable here. Please come back after some timeTRANSCHEM Stock News & Opinions
TRANSCHEM Stock News & Opinions
Articles & Videos
Corporate
Corporate
Transchem Limited acquired Greshma Shares and Stocks for Rs 25.91 crore, entering financial servicesTranschem Limited has acquired 100% of the equity shareholding of Greshma Shares and Stocks Limited (GSSL) for a consideration of Rs 25.91 crore, according to a regulatory filing. The acquisition, completed August 17, 2026, involves the purchase of 1,55,16,000 equity shares of GSSL at Rs 16.70 per share, making GSSL a wholly-owned subsidiary of Transchem Limited. The move is described as a strategic initiative to enable Transchem to enter the financial services sector, leveraging GSSL's expertise in stock broking.
4 weeks agoCapital Market - Live
Corporate
Corporate
Transchem Limited acquires 100% of Greshma Shares and Stocks for Rs 25.91 croreTranschem Limited has executed a Share Purchase Agreement with existing shareholders of Greshma Shares and Stocks Limited (GSSL), acquiring 100% of GSSL's equity shareholding for a consideration of Rs 25.91 crore, or Rs 16.70 per share. The acquisition, completed August 17, 2026, makes GSSL a wholly-owned subsidiary of Transchem Limited and marks the company's entry into the financial services sector, specifically stock broking. Regulatory approvals were obtained from NSE Clearing Limited, National Stock Exchange of India Limited, Indian Clearing Corporation Limited, BSE Limited, Central Depository Services (India) Limited, and the Securities and Exchange Board of India.
4 weeks agoCapital Market - Live
Corporate
Corporate
Transchem Limited closes trading window ahead of August board meeting for quarterly resultsTranschem Limited will hold a board meeting on August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and has closed the trading window for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the results are publicly available.
1 month agoCapital Market - Live
Earnings
Earnings
Transchem standalone net profit rises 186.30% in the March 2026 quarterNet profit of Transchem rose 186.30% to Rs 2.09 crore in the quarter ended March 2026 as against Rs 0.73 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 2.42 crore during the previous quarter ended March 2025. For the full year,net profit declined 17.78% to Rs 4.30 crore in the year ended March 2026 as against Rs 5.23 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 as against Rs 2.63 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales02.42 -100 02.63 -100 OPM %0-19.83 -0-55.13 - PBDT2.391.08 121 5.637.08 -20 PBT2.391.08 121 5.627.07 -21 NP2.090.73 186 4.305.23 -18 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Transchem to announce Quarterly ResultTranschem will hold a meeting of the Board of Directors of the Company on 5 May 2026.
4 months agoCapital Market - Live
Earnings
Earnings
Transchem standalone net profit declines 61.87% in the December 2025 quarterNet profit of Transchem declined 61.87% to Rs 0.53 crore in the quarter ended December 2025 as against Rs 1.39 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 as against Rs 0.21 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales00.21 -100 OPM %0-157.14 - PBDT0.941.86 -49 PBT0.941.86 -49 NP0.531.39 -62 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Transchem to announce Quarterly ResultTranschem will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Transchem to convene EGMTranschem announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 20 December 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Transchem to convene board meetingTranschem will hold a meeting of the Board of Directors of the Company on 21 November 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Earnings
Transchem standalone net profit declines 52.78% in the September 2025 quarterNet profit of Transchem declined 52.78% to Rs 0.68 crore in the quarter ended September 2025 as against Rs 1.44 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -19.17%, vs industry avg of 11.78%
Over the last 5 years, market share decreased from 0.01% to 0%
Over the last 5 years, net income has grown at a yearly rate of -29.22%, vs industry avg of 10.53%